| Product |
CAS |
Molecular formula |
More |
| Anagrelide related compound a (25 mg) (ethyl 2-(6-amino-2,3-dichlorobe |
85325-12-8 |
C11H15Cl3N2O2 |
More |
| Anisyl propionate |
7549-33-9 |
C10H12O3 |
More |
| 3,4-Dihydro-7-(4-hydroxybutoxy)-2(1h)-quinolinone |
889443-20-3 |
C13H17NO3 |
More |
| 2-Carboxyarticaine |
114176-52-2 |
C12H18N2O3S |
More |
| Astaxanthin |
7542-45-2 |
C40H52O4 |
More |
| 3’-N-desmethyl-3’-n-formyl azithromycin |
612069-28-0 |
C38H70N2O13 |
More |
| Bis-ethylhexyloxyphenol methoxyphenyl triazine |
187393-00-6 |
C38H49N3O5 |
More |
| Benazepril related compound g (15 mg) ((3-(1-ethoxycarbonyl-3-phenyl-( |
103129-58-4 |
C26H32N2O5 |
More |
| Benzphetamine hydrochloride--dea |
5411-22-3 |
C17H21N.ClH |
More |
| Bephenium hydroxynaphthoate |
3818-50-6 |
C28H29NO4 |
More |
| D-saccharic acid calcium salt tetrahydrate |
5793-89-5 |
C6H16CaO12 |
More |
| Betamethasone benzoate (200 mg) |
22298-29-9 |
C35H41FO8 |
More |
| Betamethasone valerate related compound a (50 mg) (betamethasone 21-va |
2240-28-0 |
C27H37FO6 |
More |
| Bisacodyl related compound c (20 mg) (4-[(4-hydroxyphenyl)(pyridin-2-y |
72901-16-7 |
C20H17NO3 |
More |
| Bisacodyl related compound e (20 mg) (2-[(4-acetoxyphenyl)(pyridin-2-y |
111664-35-8 |
C22H19NO4 |
More |
| Bismuth subgallate (2 g) (as) |
22650-86-8 |
C7H5BiO6 |
More |
| Powdered black cohosh extract (1.5 g) |
84776-26-1 |
Unspecified |
More |
| Buprenorphine hydrochloride |
53152-21-9 |
C28H40ClNO4 |
More |
| Buprenorphine related compound a cii (25 mg) (21-[3-(1-propenyl)]-7alp |
457071-73-7 |
C29H41NO4 |
More |
| Calcium gluceptate, hemiheptahydrate |
29039-00-7 |
C14H32CaO19 |
More |
